import { EducationalContent } from '../../types';

export const asd: EducationalContent = {
  id: 'asd',
  type: 'concept',
  name: 'Atrial Septal Defect',
  nameEs: 'Comunicacion Interauricular',
  levels: {
    1: {
      level: 1,
      summary: 'An atrial septal defect (ASD) is a hole in the wall between the two upper chambers of the heart that allows blood to flow abnormally between them.',
      explanation: 'An atrial septal defect, commonly called an ASD, is a type of congenital heart defect, meaning it is present from birth. The heart has four chambers: two upper chambers called atria and two lower chambers called ventricles. A wall called the septum separates the right and left sides of the heart. In a normal heart, this wall prevents blood from mixing between the two sides.\n\nIn an ASD, there is an opening or hole in the wall (septum) between the two upper chambers (atria). This hole allows oxygen-rich blood from the left atrium to flow across to the right atrium, where it mixes with oxygen-poor blood. This extra blood then flows to the lungs, making the right side of the heart and the lungs work harder than normal.\n\nASDs are one of the most common congenital heart defects, occurring in about 1 in every 1,500 live births. They are more common in females than males. Many small ASDs cause no symptoms and may close on their own during childhood. Larger ASDs may cause symptoms such as shortness of breath during exercise, fatigue, swelling in the legs or abdomen, frequent respiratory infections, and heart palpitations.\n\nDoctors can detect an ASD through a physical examination (hearing an abnormal heart sound or murmur) and confirm it with an echocardiogram, which uses sound waves to create pictures of the heart. The echocardiogram shows the location and size of the hole and how much extra blood is flowing through it.\n\nSmall ASDs that cause no symptoms may simply be monitored over time. Larger ASDs that cause significant extra blood flow to the lungs typically need to be closed. Closure can be done through open-heart surgery or, for certain types and sizes, through a catheter-based procedure where a special closure device is threaded through a blood vessel and placed across the hole to seal it. Most people who have their ASD repaired in childhood go on to lead normal, healthy lives.',
      keyTerms: [
        { term: 'Atrial septal defect (ASD)', definition: 'A hole in the wall between the two upper chambers of the heart that is present from birth' },
        { term: 'Septum', definition: 'The wall of tissue that divides the right and left sides of the heart, preventing blood from mixing' },
        { term: 'Congenital heart defect', definition: 'A heart problem that is present at birth, developing during pregnancy as the heart forms' },
        { term: 'Atria', definition: 'The two upper chambers of the heart; the right atrium receives blood from the body and the left atrium receives blood from the lungs' },
        { term: 'Closure device', definition: 'A small, specially designed plug or disc that can be placed through a catheter to seal a hole in the heart without open surgery' }
      ],
      clinicalNotes: 'Many ASDs are discovered incidentally during childhood or adulthood when a heart murmur is detected. A fixed, widely split second heart sound (S2) is the classic auscultatory finding of an ASD. Parents should be reassured that small ASDs often close spontaneously, particularly patent foramen ovale (PFO) types. Refer to pediatric cardiology for echocardiographic evaluation and follow-up planning when an ASD is suspected.'
    },
    2: {
      level: 2,
      summary: 'Atrial septal defects are classified by anatomic location (secundum, primum, sinus venosus, coronary sinus types) with left-to-right shunting causing right heart volume overload, diagnosed by echocardiography and managed with closure when hemodynamically significant.',
      explanation: 'Atrial septal defects represent abnormal communications between the left and right atria resulting from failure of normal septation during embryologic development. The interatrial septum forms through a complex process involving the septum primum and septum secundum, and defects in this process produce ASDs at different anatomic locations.\n\nSecundum ASD is the most common type, accounting for approximately 75% of all ASDs. It occurs in the central portion of the interatrial septum at the fossa ovalis, the region where the septum primum and septum secundum overlap. This results from deficiency of the septum primum, excessive resorption of the septum primum, or deficiency of the septum secundum. Secundum ASDs are most amenable to percutaneous device closure.\n\nPrimum ASD (also called partial atrioventricular septal defect) accounts for approximately 15-20% of ASDs. It occurs in the inferior portion of the atrial septum, adjacent to the atrioventricular valves. Primum ASDs are frequently associated with a cleft in the anterior leaflet of the mitral valve, which can cause mitral regurgitation. They are particularly common in Down syndrome (trisomy 21).\n\nSinus venosus ASD accounts for approximately 5-10% of ASDs and occurs at the junction of the superior vena cava (superior type, most common) or inferior vena cava (inferior type, rare) with the right atrium. Superior sinus venosus ASDs are commonly associated with anomalous drainage of the right upper pulmonary vein into the superior vena cava or right atrium (partial anomalous pulmonary venous return, PAPVR).\n\nCoronary sinus ASD (unroofed coronary sinus) is the rarest type, resulting from a deficiency in the wall between the coronary sinus and the left atrium, creating a communication through the coronary sinus ostium.\n\nThe hemodynamic consequence of an ASD is a left-to-right shunt. Because the right ventricle is more compliant than the left ventricle, blood preferentially flows from the left atrium through the defect into the right atrium. This creates volume overload of the right atrium, right ventricle, and pulmonary circulation. The degree of shunting depends on the defect size and the relative compliance of the two ventricles.\n\nDiagnostic evaluation includes transthoracic echocardiography (TTE) as the initial study, demonstrating right heart enlargement, the defect itself, and Doppler-confirmed shunt flow. Agitated saline contrast (bubble study) can confirm right-to-left shunting if present. Transesophageal echocardiography (TEE) provides superior anatomic detail, particularly for sizing the defect and evaluating rims before percutaneous closure. The Qp:Qs ratio (pulmonary-to-systemic flow ratio) quantifies shunt magnitude; a ratio greater than 1.5:1 with right heart dilation generally indicates the need for closure.\n\nTreatment depends on defect type, size, and hemodynamic significance. Percutaneous device closure using the Amplatzer Septal Occluder or similar devices is the preferred approach for secundum ASDs with adequate tissue rims (at least 5 mm, except for the aortic rim). Surgical closure is required for primum ASDs (which also require mitral valve repair), sinus venosus ASDs (often requiring patch closure and baffle of anomalous pulmonary veins), and large secundum ASDs with insufficient rims for device closure.',
      keyTerms: [
        { term: 'Secundum ASD', definition: 'The most common type of atrial septal defect, occurring at the fossa ovalis in the central interatrial septum; most amenable to percutaneous closure' },
        { term: 'Primum ASD', definition: 'An ASD in the inferior atrial septum adjacent to the AV valves, often associated with a cleft mitral valve and common in Down syndrome' },
        { term: 'Sinus venosus ASD', definition: 'An ASD at the junction of the SVC or IVC with the right atrium, frequently associated with partial anomalous pulmonary venous return' },
        { term: 'Left-to-right shunt', definition: 'Abnormal flow of oxygenated blood from the left side of the heart to the right side through a defect, causing volume overload of the pulmonary circulation' },
        { term: 'Qp:Qs ratio', definition: 'The ratio of pulmonary to systemic blood flow used to quantify shunt magnitude; values greater than 1.5:1 indicate hemodynamically significant shunting' },
        { term: 'Amplatzer Septal Occluder', definition: 'A self-expanding double-disc device delivered through a catheter to close secundum ASDs without surgery' }
      ],
      clinicalNotes: 'The classic physical exam findings of an ASD include a widely split and fixed S2 (because the right ventricle has a relatively constant, increased volume regardless of respiratory phase), a systolic flow murmur across the pulmonic valve (due to increased flow, not valve disease), and occasionally a diastolic rumble across the tricuspid valve with large shunts. ECG typically shows right axis deviation and incomplete right bundle branch block pattern (rSR-prime in V1). Chest X-ray may reveal cardiomegaly with prominent pulmonary vasculature.'
    },
    3: {
      level: 3,
      summary: 'ASD management requires comprehensive assessment of shunt hemodynamics, associated anomalies, pulmonary vascular resistance, and careful selection between percutaneous and surgical closure based on anatomic suitability, with long-term surveillance for arrhythmias and pulmonary hypertension.',
      explanation: 'Advanced management of atrial septal defects integrates detailed anatomic and hemodynamic assessment with individualized treatment strategies, accounting for associated anomalies, timing of intervention, and long-term sequelae.\n\nThe embryology of interatrial septation is essential for understanding ASD morphology. The septum primum grows downward from the roof of the common atrium toward the endocardial cushions, with its leading edge initially leaving an opening called the ostium primum. As the septum primum fuses with the endocardial cushions (closing the ostium primum), perforations develop in the upper portion of the septum primum, coalescing to form the ostium secundum. The septum secundum then grows downward to the right of the septum primum, creating a flap-valve arrangement (the foramen ovale) that allows right-to-left flow in fetal life. Failure of septum primum development at different stages results in different ASD types.\n\nHemodynamic assessment goes beyond simple Qp:Qs calculation. The magnitude of shunting is influenced by ASD size, relative ventricular compliance, pulmonary vascular resistance, and coexisting conditions. In young patients, the highly compliant right ventricle accepts the volume load with modest right atrial pressure elevation. With aging, decreased left ventricular compliance from hypertension, coronary disease, or diastolic dysfunction progressively increases the left-to-right shunt, explaining why some patients become symptomatic in their 40s-60s despite having the defect since birth.\n\nCatheterization for ASD evaluation includes right heart catheterization with oxygen saturation sampling (demonstrating a step-up at the atrial level), measurement of pulmonary artery pressures and pulmonary vascular resistance (PVR), and assessment of Qp:Qs. Elevated PVR (greater than 5 Wood units) raises concern for Eisenmenger syndrome (irreversible pulmonary vascular disease with shunt reversal). ASD closure is contraindicated when PVR is greater than two-thirds of systemic vascular resistance or when net right-to-left shunting is present. In borderline cases (PVR 5-8 Wood units), pulmonary vasoreactivity testing with inhaled nitric oxide, epoprostenol, or oxygen may identify patients who can safely undergo closure, sometimes after a period of targeted pulmonary vasodilator therapy.\n\nPercutaneous closure technique involves TEE or intracardiac echocardiography (ICE) guidance, balloon sizing of the defect, and deployment of an appropriately sized closure device. The device must be seated with adequate septal rims to provide stable anchoring. Critical sizing parameters include the aortic rim (anterosuperior), the SVC rim (superoposterior), the IVC rim (inferoposterior), the posterior rim, and the AV valve rim (inferior). A deficient aortic rim (less than 5 mm) is the most common rim deficiency and is generally not a contraindication to closure, but other rim deficiencies may preclude percutaneous approach. Post-procedure, patients receive dual antiplatelet therapy (aspirin plus clopidogrel) for 6 months and aspirin alone for an additional 6 months, with endocarditis prophylaxis for 6 months until the device is endothelialized.\n\nSurgical closure techniques include primary suture closure for small defects and patch closure (autologous pericardium or synthetic material) for larger defects. Minimally invasive approaches through a right mini-thoracotomy or robotic-assisted surgery offer cosmetic advantages and faster recovery compared to full median sternotomy. Surgical mortality is less than 1% in experienced centers.\n\nLong-term outcomes and surveillance: ASD closure before age 25 is associated with normal life expectancy. Closure after age 40 improves symptoms and prevents further right heart dilation but carries increased risk of atrial arrhythmias (atrial fibrillation and flutter) compared to early closure. Late complications include device erosion (rare, approximately 0.1% for Amplatzer devices, typically occurring within 72 hours), residual shunts (small, usually clinically insignificant), thrombus formation on the device, and atrial arrhythmias. All patients require long-term follow-up with periodic echocardiography.',
      keyTerms: [
        { term: 'Eisenmenger syndrome', definition: 'Irreversible pulmonary vascular disease resulting from chronic left-to-right shunting that leads to pulmonary hypertension and eventual shunt reversal to right-to-left flow with cyanosis' },
        { term: 'Pulmonary vascular resistance (PVR)', definition: 'The resistance to blood flow through the pulmonary vascular bed, measured in Wood units; elevated PVR may contraindicate ASD closure' },
        { term: 'Balloon sizing', definition: 'A technique during cardiac catheterization where a compliant balloon is inflated across the ASD to measure the stretched diameter, guiding device size selection' },
        { term: 'Septal rims', definition: 'The tissue borders surrounding an ASD that provide anchoring for percutaneous closure devices; adequate rims (typically greater than 5 mm) are required for stable device placement' },
        { term: 'Ostium primum', definition: 'The embryologic opening between the lower edge of the septum primum and the endocardial cushions; persistent patency results in a primum ASD' },
        { term: 'Device erosion', definition: 'A rare but serious complication of percutaneous ASD closure where the device erodes into adjacent structures (aorta, atrial roof), potentially causing tamponade' }
      ],
      clinicalNotes: 'Before percutaneous closure, TEE or ICE assessment of all five septal rims is mandatory. The stretched balloon diameter should be used for device sizing (typically 1-2 mm larger than the balloon waist). Post-closure monitoring should include TTE at 1 month, 6 months, and 12 months, then annually. Bubble contrast study should be performed at 6 months to confirm complete closure. New atrial fibrillation after ASD closure should prompt evaluation for device-related complications. Pregnancy in women with uncorrected hemodynamically significant ASDs carries increased risk of paradoxical embolism and arrhythmias; pre-pregnancy closure is recommended.'
    },
    4: {
      level: 4,
      summary: 'Complex ASD management involves multi-defect closure strategies, management of associated anomalies including PAPVR, catheter-based closure in challenging anatomy, Eisenmenger physiology management, and adult congenital heart disease expertise for late-presenting patients with established sequelae.',
      explanation: 'Advanced ASD management addresses complex anatomic variants, challenging clinical scenarios, and emerging techniques that require specialized congenital heart disease expertise.\n\nMulti-fenestrated atrial septum (Swiss cheese septum) presents multiple small defects throughout the septum that collectively create significant shunting. Percutaneous management may require multiple devices or a single large device covering the entire septal region. The cribriform variant of the Amplatzer device, with its flat disc profile and smaller connecting waist, is specifically designed for this anatomy. In some cases, a combination approach using one or two devices for the largest defects with residual small shunts expected to close spontaneously or remain hemodynamically insignificant may be appropriate.\n\nASD with partial anomalous pulmonary venous return (PAPVR) requires careful pre-procedural imaging (typically cardiac CT or MRI) to define the anatomy of all four pulmonary veins. Sinus venosus ASDs with PAPVR most commonly involve the right upper pulmonary vein draining into the SVC. Surgical repair requires redirection of anomalous veins to the left atrium, typically using a baffle technique (Warden procedure for SVC-type PAPVR, involving transection of the SVC above the anomalous vein entry with anastomosis of the SVC to the right atrial appendage, and patch baffling of pulmonary venous flow through the ASD to the left atrium). Complications include SVC obstruction and pulmonary venous obstruction, requiring careful surgical technique.\n\nASD in the elderly patient presents unique challenges. Patients presenting after age 60 often have atrial fibrillation, elevated left atrial pressure from diastolic dysfunction, and varying degrees of pulmonary hypertension. Paradoxically, ASD closure in elderly patients with significantly elevated left atrial pressure may be poorly tolerated because the ASD serves as a pop-off valve decompressing the left atrium. A balloon occlusion test during catheterization, monitoring left atrial pressure during temporary balloon occlusion of the ASD, can predict hemodynamic tolerance of closure. A significant rise in left atrial pressure (greater than 3 mmHg) suggests that closure may precipitate pulmonary congestion, and a fenestrated device or medical optimization before closure may be advisable.\n\nASD and cryptogenic stroke: Patent foramen ovale (PFO) is found in approximately 25% of the general population and is present at higher rates (40-50%) in patients with cryptogenic stroke, particularly in younger patients. The RoPE (Risk of Paradoxical Embolism) score helps estimate the probability that a PFO is pathologically related to a cryptogenic stroke based on age, cortical infarct pattern, and absence of traditional risk factors. The CLOSE, RESPECT, and DEFENSE-PFO trials demonstrated that percutaneous PFO closure reduces recurrent stroke risk compared to medical therapy alone in appropriately selected patients under age 60 with high-risk PFO features (large shunt, atrial septal aneurysm). Antiplatelet therapy is typically used after PFO closure rather than anticoagulation.\n\nCardiac magnetic resonance (CMR) imaging provides comprehensive assessment of ASD patients including precise Qp:Qs calculation using phase-contrast velocity mapping, right ventricular volume and function quantification (more accurate than echocardiography), identification and characterization of all pulmonary venous connections, and assessment of myocardial fibrosis. CMR is particularly valuable for sinus venosus ASDs, which are frequently missed by TTE.\n\nManagement of Eisenmenger syndrome in ASD patients requires a specialized multidisciplinary approach. Advanced pulmonary vasodilator therapy using phosphodiesterase-5 inhibitors (sildenafil, tadalafil), endothelin receptor antagonists (bosentan, ambrisentan, macitentan), and prostacyclin pathway agents (epoprostenol, treprostinil, selexipag) can improve functional capacity and hemodynamics. The BREATHE-5 trial demonstrated safety and efficacy of bosentan in Eisenmenger patients. ASD closure is contraindicated in established Eisenmenger syndrome, but a treat-and-close strategy (pulmonary vasodilator therapy to reduce PVR followed by ASD closure, sometimes with a fenestrated device) is being investigated in selected patients with reversible pulmonary vascular disease.',
      keyTerms: [
        { term: 'Multi-fenestrated septum', definition: 'A Swiss cheese pattern of multiple small ASDs throughout the interatrial septum that collectively produce hemodynamically significant shunting' },
        { term: 'Warden procedure', definition: 'A surgical technique for sinus venosus ASD with PAPVR involving SVC transection, SVC-to-right atrial appendage anastomosis, and baffle redirection of anomalous pulmonary veins through the ASD' },
        { term: 'Balloon occlusion test', definition: 'Temporary balloon inflation to occlude an ASD during catheterization while monitoring hemodynamics to predict tolerance of permanent closure, particularly in elderly patients' },
        { term: 'RoPE score', definition: 'Risk of Paradoxical Embolism score; a clinical tool estimating the probability that a PFO is causally related to a cryptogenic stroke, guiding closure decisions' },
        { term: 'Fenestrated closure device', definition: 'A modified ASD closure device with intentional small perforations that allow limited right-to-left decompression, used when complete closure risks elevating left atrial pressure' },
        { term: 'Treat-and-close strategy', definition: 'An investigational approach for ASD patients with elevated PVR involving pulmonary vasodilator therapy to reduce pulmonary pressures before attempting defect closure' }
      ],
      clinicalNotes: 'For elderly patients undergoing ASD closure, preprocedural right heart catheterization with balloon occlusion testing is strongly recommended. A rise in PCWP greater than 3 mmHg during occlusion warrants aggressive diuresis and afterload reduction before reattempting closure or using a fenestrated device. All sinus venosus ASDs require cross-sectional imaging (CT or MRI) to define pulmonary venous anatomy before surgical repair. PFO closure for cryptogenic stroke should follow a multidisciplinary evaluation (neurology, cardiology) and is most beneficial in patients younger than 60 with a RoPE score of 7 or higher.'
    },
    5: {
      level: 5,
      summary: 'Expert-level ASD management encompasses transcatheter innovations for challenging anatomy, computational modeling for device selection and hemodynamic prediction, genetic underpinnings of atrial septation defects, bioabsorbable closure technologies, and emerging paradigms in adult congenital heart disease surveillance.',
      explanation: 'Expert-level ASD management integrates cutting-edge interventional techniques, molecular biology, computational science, and longitudinal care models that represent the frontier of congenital heart disease management.\n\nTranscatheter innovations for complex ASDs include the development of bioabsorbable closure devices that provide structural support during healing and then dissolve, eliminating long-term foreign body implantation. The BioSTAR device was an early attempt using a bioengineered collagen matrix, and current research focuses on polymer-based frameworks (poly-L-lactic acid, polyglycolic acid) seeded with autologous cells to promote tissue ingrowth and natural septum regeneration. Three-dimensional printing of patient-specific septal anatomy from CT or MRI data enables preprocedural simulation, device sizing optimization, and prediction of potential complications such as erosion risk based on geometric analysis of the defect-to-aortic root relationship.\n\nComputational fluid dynamics (CFD) modeling of atrial hemodynamics allows simulation of shunt physiology before and after closure. Patient-specific CFD models can predict post-closure hemodynamic changes including left atrial pressure elevation, changes in left ventricular filling dynamics, and the impact of fenestrated versus non-fenestrated closure. Machine learning algorithms trained on large ASD registries can predict closure outcomes (success, complications, residual shunt) from preprocedural imaging data, potentially improving patient selection and device choice.\n\nThe genetics of atrial septation are increasingly understood. NKX2-5 mutations cause familial secundum ASDs with progressive AV conduction disease (first degree to complete heart block). TBX5 mutations cause Holt-Oram syndrome (upper limb malformations with secundum ASD). GATA4 mutations are associated with familial ASDs and may also cause ventricular septal defects. Epigenetic regulation of cardiac transcription factors during septation is an active area of research that may eventually enable prenatal prediction and prevention of congenital heart defects. Copy number variants (22q11.2 deletion syndrome) can include ASDs among their cardiac manifestations.\n\nRight ventricular remodeling after ASD closure follows predictable patterns that can be monitored with CMR. RV volumes decrease by approximately 30-40% within 6 months of closure in most patients, with near-normalization by 12-24 months. However, patients with late closure (after age 40) or those with pre-existing RV fibrosis (detected by CMR late gadolinium enhancement) may have incomplete reverse remodeling. RV strain analysis using CMR feature tracking provides more sensitive assessment of RV functional recovery than volumetric analysis alone. Persistent RV dysfunction after successful closure should prompt evaluation for concurrent pulmonary vascular disease or myocardial fibrosis.\n\nAtrial arrhythmia management in ASD patients represents a significant clinical challenge. Pre-closure atrial fibrillation or flutter is present in 10-15% of adult ASD patients and persists in the majority after closure. Combined ASD closure with catheter ablation (pulmonary vein isolation for AF, cavotricuspid isthmus ablation for typical flutter) in a single procedure is increasingly performed. The atrial substrate in long-standing ASD includes right atrial dilation, fibrosis, and altered conduction patterns that may require more extensive ablation strategies. A prophylactic right atrial maze procedure can be performed during surgical ASD repair in patients with documented paroxysmal AF.\n\nLong-term surveillance models for adult congenital heart disease (ACHD) incorporate wearable monitoring devices for continuous arrhythmia detection, remote echocardiographic screening using handheld devices with AI interpretation, and structured transition programs from pediatric to adult congenital care. Digital health platforms integrating patient-reported outcomes, wearable data, and serial imaging create comprehensive longitudinal datasets for individual risk assessment and population-level research. International registries (CONCOR, SWEDCON, APPROACH) provide essential data on ultra-long-term outcomes after ASD intervention.\n\nThe concept of residual hemodynamic lesions recognizes that even after successful ASD closure, patients may retain subclinical abnormalities including subtle RV systolic dysfunction, abnormal exercise hemodynamics, and atrial myopathy that increase long-term risk of heart failure and arrhythmias. This understanding has shifted the paradigm from viewing ASD closure as a cure to recognizing it as one milestone in a chronic condition requiring lifelong surveillance.',
      keyTerms: [
        { term: 'Bioabsorbable closure devices', definition: 'Experimental ASD closure devices made from biodegradable polymers that provide temporary structural support during healing then dissolve, avoiding permanent foreign body implantation' },
        { term: 'NKX2-5', definition: 'A cardiac transcription factor gene whose mutations cause familial secundum ASDs with progressive atrioventricular conduction disease' },
        { term: 'Computational fluid dynamics', definition: 'Mathematical simulation of blood flow through patient-specific cardiac anatomy to predict hemodynamic changes from ASD closure and optimize device selection' },
        { term: 'Right ventricular reverse remodeling', definition: 'The process of RV size and function normalization after ASD closure, typically occurring over 6-24 months; monitored by serial echocardiography or CMR' },
        { term: 'Residual hemodynamic lesions', definition: 'Subclinical cardiac abnormalities persisting after ASD closure including RV dysfunction, atrial myopathy, and exercise hemodynamic impairment that warrant long-term surveillance' },
        { term: 'Combined ASD closure and ablation', definition: 'A hybrid procedure performing percutaneous ASD device closure and catheter ablation of atrial arrhythmias in a single session to address both structural and electrophysiologic pathology' }
      ],
      clinicalNotes: 'Genetic testing should be considered in patients with familial ASD patterns, associated conduction disease, or syndromic features. NKX2-5 mutation carriers require ongoing monitoring for progressive heart block even after successful ASD closure. For patients undergoing combined closure and ablation, the ablation should typically be performed before device deployment to allow catheter access across the septum. Post-closure CMR at 12 months provides definitive assessment of RV reverse remodeling and can identify patients requiring ongoing surveillance versus those who can be transitioned to less frequent follow-up. All adult ASD patients, whether repaired or unrepaired, should be followed lifelong at an accredited ACHD center.'
    }
  },
  media: [],
  citations: [
    { id: 'asd-c1', source: 'Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the Management of Adult Congenital Heart Disease. Eur Heart J. 2021;42(6):563-645.', url: 'https://doi.org/10.1093/eurheartj/ehaa554' },
    { id: 'asd-c2', source: 'Stout KK, Daniels CJ, Perloff RK, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease. Circulation. 2019;139(14):e698-e800.', url: 'https://doi.org/10.1161/CIR.0000000000000603' },
    { id: 'asd-c3', source: 'Mas JL, Derumeaux G, Guillon B, et al. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke. N Engl J Med. 2017;377(11):1011-1021.', url: 'https://doi.org/10.1056/NEJMoa1705915' }
  ],
  crossReferences: [
    { contentId: 'vsd', relationship: 'related', description: 'Ventricular septal defect is another common congenital heart defect involving abnormal septal communication' },
    { contentId: 'echo', relationship: 'related', description: 'Echocardiography is the primary diagnostic tool for ASD detection, sizing, and follow-up' },
    { contentId: 'cardiaccath', relationship: 'related', description: 'Cardiac catheterization provides hemodynamic assessment and enables percutaneous ASD closure' }
  ],
  tags: {
    defined: ['congenital-heart-disease', 'atrial-septal-defect', 'shunt-lesion', 'structural-heart', 'percutaneous-closure', 'adult-congenital'],
    generated: ['secundum-ASD', 'primum-ASD', 'sinus-venosus', 'PFO', 'Eisenmenger', 'device-closure']
  },
  createdAt: '2025-01-25',
  updatedAt: '2025-01-25',
  version: 2,
  status: 'published'
};
